NeuroMetrix, Inc. to Exhibit at the 2012 Diabetic Foot Global Conference

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes will be an exhibiting sponsor at the Diabetic Foot Global Conference (DFCon) from March 15-17 in Los Angeles.

MORE ON THIS TOPIC